Utilization rates of radiological examinations in pregnant women rose dramatically over the last decade, driven largely by CT studies of the head and CT pulmonary angiography (CTPA). In one of the first studies to evaluate rates of radiological examinations that expose pregnant women to ionizing radiation, the number of exams per patient population was found to have risen by 81% over the period, according to research presented at the RSNA meeting by Dr. Elizabeth Lazarus of Brown University.
In 2006, CT pulmonary angiography was the most common CT exam performed on pregnant women.
Utilization rates of radiological examinations in pregnant women rose dramatically over the last decade, driven largely by CT studies of the head and CT pulmonary angiography (CTPA). In one of the first studies to evaluate rates of radiological examinations that expose pregnant women to ionizing radiation, the number of exams per patient population was found to have risen by 81% over the period, according to research presented at the RSNA meeting by Dr. Elizabeth Lazarus of Brown University.
The study looked at radiographic plain film, nuclear medicine, and CT studies performed on pregnant women over 10 years, from 1997 to 2006, at a single academic medical center. MR and ultrasound were not included as they do not impart radiation to the patient. Fluoroscopic and interventional radiology exams were excluded from the study because so few of them were performed on the population during the study period.All imaging examinations that expose pregnant women, including inpatients, outpatients, and emergency department patients, to radiation are recorded in a database at Lazarus' institution. A retrospective review of the database found that 5235 radiology examinations were performed on 3249 pregnant patients over the 10 years.CT utilization rates rose most sharply -- by an average of 25% per year -- Lazarus found. Average growth rates for plain film and nuclear medicine studies were more modest, with utilization of plain film growing by 6.8% and nuclear medicine by 17%, on average.These results could cause some concern, as CT imparts the greatest amounts of radiation to the patient. Exposure to radiation has been linked to such fetal risks as central nervous system defects and increased incidence of childhood leukemia and other malignancies. In addition, pregnant women may be more vulnerable to the adverse effects of increased radiation.CT studies of the abdomen and pelvis impart an average dose of 20 mGy to the fetus, by far the largest average dose of all studies. However, that dose still falls within the medically allowable radiation threshold of 50 mGy.In addition, more than 60% of CT studies performed impart much lower doses of radiation to the fetus. Head studies account for 37% of CT exams, and the approximate radiation dose to the fetus is less than 0.01 mGy. CTPA, which accounts for 27% of CT studies performed on pregnant women, imparts an approximate radiation dose of less than 0.1 mGy to the fetus.Other approximate radiation doses include less than 1 mGy for nuclear medicine studies and for plain-film studies where the fetus is in the beam. When the fetus is not in the beam, the radiation dose to the fetus is less than 0.01 mGy for plain-film studies.Radiation dose to the pregnant woman's breast tissue during exams is another area of concern. According to Lazarus, the approximate radiation dose to the breast during CTPA is 20 mGy, which is equivalent to four mammograms.CTPA was the most common radiological examination performed on pregnant women, Lazarus found.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.